[ET Net News Agency, 27 June 2025] Morgan Stanley lowered the target price for Trad
Chinese Med (00570) to HKD1.6 from HKD1.7 and maintained the "underweight" rating.
The research house said it cuts earnings estimates by 8-13% over 2025-2030, driven by
further price cuts (lower gross margins) and sales declines at the formula granules
business. (rc)